IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats

BACKGROUND: Intestinal barrier dysfunction is not only the consequence of liver cirrhosis, but also an active participant in the development of liver cirrhosis. Previous studies showed that external administration of insulin-like growth factor 1 (IGF-1) improved intestinal barrier function in liver...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Gastroenterol
Päätekijät: Zhao, Tian-Yu, Su, Li-Ping, Ma, Chun-Ye, Zhai, Xiao-Han, Duan, Zhi-Jun, Zhu, Ying, Zhao, Gang, Li, Chun-Yan, Wang, Li-Xia, Yang, Dong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495682/
https://ncbi.nlm.nih.gov/pubmed/26152281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0311-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia